The peritoneum is the preferred and most common location for placement of the distal terminus of a cerebrospinal fluid (CSF) shunt. However, there are instances in which the peritoneum is not a suitable place for the shunt, such as in the case of a congenital abnormality, infection, or extensive adhesions, which may prevent absorption of CSF. In such cases, other anatomic locations are considered, including the right cardiac atrium and pleural cavity.
In some patients, all of the routine distal sites are unsuitable. These patients often have complex problems and have experienced multiple shunt failures or infections. Examples include prematurely born infants with necrotizing enterocolitis and patients with congenital diaphragmatic hernia, spina bifida, or history of shunt infection. Other potential problematic situations include congenital diaphragmatic hernia, spina bifida, and history of shunt infection. Tuberculosis can cause abdominal, pulmonary, and intracranial problems, and these complications are continuing problems worldwide.1 In patients with complex hydrocephalus, another distal site might be required.
The gallbladder is a potentially effective location when the more common sites for distal shunt placement have failed. This concept was first explored in 1958 by Smith et al.2 The gallbladder is an effective distal terminus of a shunt because the bile is sterile, the intestinal tract will effectively absorb electrolytes, and the lytic nature of the bile might prevent scarring and distal catheter occlusion. However, experience with ventriculo-gallbladder (VGB) shunts is limited. Placement of a VGB shunt is considered a salvage procedure because of the high complication rate.
Surgical planning is essential for every shunt-placement surgery, and the procedure should be performed in collaboration with an experienced general surgeon.
Imaging studies must be performed to evaluate for the presence and size of the gallbladder. Imaging is used also to identify any disease process that can hinder the surgery. Possible conditions that would preclude surgery include extensive cholelithiasis or cholecystitis. Patients with hepatic or pancreatic disease are not suitable candidates for VGB shunt placement. Cholestatic jaundice is relatively common in infants who require long-term total parenteral nutrition; therefore, more extensive evaluation of hepatic and gallbladder function might be necessary for these patients.3
A 1-way flow valve has to be chosen to prevent biliary reflux. The distal resistance must be considered in valve selection. The distal resistance is assumed to be zero in ventriculoperitoneal (VP) and ventriculoatrial (VA) shunts, and thus the resistance to CSF flow is assumed to be the same as the resistance of the valve. However, the intrinsic pressure of the biliary tree adds approximately 10 to 20 cm H20 resistance to the shunt system.3 Therefore, a low-pressure or programmable valve set to a low resistance should be chosen.
The patient’s ventricular anatomy is examined, and the site of the proximal catheter is selected in the same fashion as that when performing VP shunt placement.
Preoperative antibiotics are given. A widely accepted protocol for reducing the risk of infection is provided by the Hydrocephalus Research Network.4 Because the use of VGB shunts is rare compared to that of standard VP and VA shunts, not enough evidence is available to recommend a certain prophylactic antibiotic regimen. Coverage for Gram-negative organisms (gentamycin or a third-generation cephalosporin) is often added to the standard antibiotic regimen. However, the organism cultured most commonly from infected VGB shunts is Staphylococcus epidermidis, which indicates that VGB infections have an etiology similar to that of VP shunts.3
Placement of the proximal catheter is performed in the same manner as for a VP shunt. This technique is described in the VP shunt placement chapter.
The general surgeon chooses the abdominal approach. Both open and laparoscopic techniques can be used effectively, depending on the experience and preference of the general surgeon. Communication between the surgical teams before surgery is essential for ensuring that the operating room is equipped properly for the procedure.
The proximal shunt system and valve are placed by the neurosurgeon in the standard fashion. A tunneling device is used to bring the distal catheter toward the abdominal incision. Before placing the distal catheter into the abdominal cavity, the distal end is modified to facilitate securing it to the gallbladder wall. A metallic straight connecter is attached to the distal end and then connected to another 2-cm section of distal catheter and secured with nonabsorbable suture.
The distal catheter is then placed into the peritoneal cavity through an incision or port, depending on whether the exposure is open or laparoscopic, respectively.
The dome of the gallbladder is exposed. Two concentric purse-string sutures are placed in the gallbladder using nonabsorbable 3.0 sutures. A small puncture, just large enough to allow passage of the distal 2-cm catheter segment, is made at the center of the purse string. This distal segment is then placed into the gallbladder. The inner purse string is tightened over the metal connector, and the outer purse string is then tightened to invert the complex. The metallic connector prevents occlusion of the catheter lumen when the purse-string sutures are tightened.
It is important to secure the catheter to the gallbladder to prevent the distal end from migrating into the peritoneal space, which presumably has already failed. Also, an open hole in the gallbladder wall can allow leakage of bile and subsequent peritonitis. Finally, excess catheter is coiled loosely over the liver.
VGB shunt placement confers the same risk of all the inherent complications that can occur with the placement of a VP shunt, including malfunction and infection. Very few published articles have detailed experience with VGB shunts. In the largest case series, 9 (36%) of 25 shunts were eventually removed as a result of infection.3 The infecting organisms were similar to those found in patients with a standard VP shunt (S epidermidis is the most commonly found pathogen) except in 1 patient, who developed an enteric fistula. The literature has insufficient data regarding the failure rate, but it is presumed to be higher than those for VP and VA shunt failure.
Complications specific to VGB shunts can also occur. Gallbladder atony or cholestasis can occur in response to surgery, spasm of the sphincter of Oddi, or perioperative narcotic use. This complication may be treated with intravenous cholecystokinin. Reflux of bile causing meningitis or ventriculitis has been reported also.5,6 Fracture of the distal tubing can allow bile to reflux into the peritoneal space and cause peritonitis.7
Because placement of a VGB shunt is generally reserved for use as a salvage procedure, patients undergoing the surgery often have multiple medical comorbidities. Patients should be carefully observed for abdominal complications, shunt failure, and pulmonary edema.
For any future procedures, it is important to remember that the distal catheter is fastened to the gallbladder wall. Removing the distal catheter requires care. Forced traction can result in tearing of the gallbladder. When a distal catheter requires revision, I ask the general surgical team to expose the catheter and tie it off just outside the gallbladder wall. The catheter is then cut and removed proximally, leaving a small remnant in place. If the shunt fails because of cholelithiasis or cholecystitis, the entire gallbladder is removed.
Although rarely used as such, the gallbladder can be an effective distal terminus for a CSF shunt in certain patients with a complex condition. Surgeons treating complex hydrocephalus should be familiar with this technique and its potential complications.
Contributor: Daniel Fulkerson, MD
- Lyngdoh BT, Islam MS. Ventriculocholecysto shunt: a solution to recurrent shunt complications in comorbid post-tubercular hydrocephalus with tubercular adhesive peritonitis. Acta Neurochir (Wien) 2012;154:2267–2270. doi.org/10.1007/s00701-012-1506-y.
- Smith GW, Moretz WH, Pritchard WL. Ventriculo-biliary shunt; a new treatment for hydrocephalus. Surg Forum 1958;9:701–705.
- West KW, Turner MK, Vane DW, et al. Ventricular gallbladder shunts: an alternative procedure in hydrocephalus. J Pediatr Surg 1987;22:609–612.
- Kestle JR, Holubkov R, Douglas Cochrane D, et al. A new Hydrocephalus Clinical Research Network protocol to reduce cerebrospinal fluid shunt infection. J Neurosurg Pediatr 2016;17:391–396. doi.org/10.3171/2015.8.PEDS15253.
- Barami K, Sood S, Ham S, et al. Chemical meningitis from bile reflux in a lumbar-gallbladder shunt. Pediatr Neurosurg 1998;29:328–330. doi.org/10.1159/000028748.
- Bernstein RA, Hsueh W. Ventriculocholecystic shunt. A mortality report. Surg Neurol 1985;23:31–37.
- Kulwin CG, Margaron FC, Leys CM, et al. Ventriculogallbladder shunt fracture: bile peritonitis. J Neurosurg Pediatr 2014;13:94. doi.org/10.3171/2013.10.PEDS13289.
Please login to post a comment.